Stay updated on TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial page.

Latest updates to the TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial page
- ChecktodayChange DetectedAdded a new publication entry for KEYNOTE-522 Japan Subgroup Analysis (Cancer Sci. 2026 Apr;117(4):1106-1116; doi:10.1111/cas.70307). The prior entry listing 'Online ahead of print' was replaced with the April 2026 citation.SummaryDifference0.0%

- Check7 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedLocation label updated from Napoli, Italy 80131 to Naples, Italy 80131 and version updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check36 days agoChange DetectedThe study record metadata now shows revision v3.4.3, replacing the previous v3.4.2.SummaryDifference0.0%

- Check43 days agoChange DetectedAdded a publication reference by Kuemmel et al. about KEYNOTE-522 in Ann Surg Oncol to the Publications section.SummaryDifference0.0%

- Check65 days agoChange DetectedAdded Revision: v3.4.2. Removed the government funding status notice and the earlier Revision: v3.4.1.SummaryDifference0.1%

- Check72 days agoChange DetectedA new global notice about government funding and operating status has been added to the top of the page, and the version number has been updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TNBC Neoadjuvant and Adjuvant Pembrolizumab Clinical Trial page.